References
- Apalla Z, Lallas A, Sotiriou E, Lazaridou E, Ioannides D. Epidemiological trends in skin cancer. Dermatol Pract Concept. 2017;7(2):1–6. Available from: http://dx.doi.org/10.5826/dpc.0702a01
- Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021;11(1):4337. Available from: http://dx.doi.org/10.1038/s41598-021-83502-8
- Oyasiji T, Tan W, Kane J III, Skitzki J, Francescutti V, Salerno K, et al. Malignant adnexal tumors of the skin: a single institution experience. World J Surg Oncol. 2018;16(1). Available from: http://dx.doi.org/10.1186/s12957-018-1401-y
- Martinez SR. Rare tumors through the looking glass: An examination of malignant cutaneous adnexal tumors. Arch Dermatol. 2011;147(9):1058. Available from: http://dx.doi.org/10.1001/archdermatol.2011.229
- Zaballos P, Gómez-Martín I, Martin JM, Bañuls J. Dermoscopy of adnexal tumors. Dermatol Clin. 2018;36(4):397–412. Available from: http://dx.doi.org/10.1016/j.det.2018.05.007
- Płachta I, Kleibert M, Czarnecka AM, Spałek M, Szumera-Ciećkiewicz A, Rutkowski P. Current diagnosis and treatment options for cutaneous adnexal neoplasms with apocrine and eccrine differentiation. Int J Mol Sci. 2021;22(10):5077. Available from: http://dx.doi.org/10.3390/ijms22105077
- Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the management of non-melanoma skin cancer (NMSC). Healthcare (Basel). 2017;5(4). Available from: http://dx.doi.org/10.3390/healthcare5040082
- Kleibert M, Płachta I, Czarnecka AM, Spałek MJ, Szumera-Ciećkiewicz A, Rutkowski P. Treatment of malignant adnexal tumors of the skin: A 12-year perspective. Cancers (Basel). 2022;14(4):998. Available from: http://dx.doi.org/10.3390/cancers14040998